Diagnostics firms should still get fair valuation in IPOs: Thyrocare’s Velumani

Thyrocare Technologies Ltd had made a spectacular debut on the stock exchanges two years ago. But its share prices have fallen from the highs, prompting the diagnostics company to buy the stock back from the market to show its confidence. Its larger peer Dr Lal PathLabs Ltd, which became the ......